Effect of a genetically engineered interferon-alpha versus traditional interferon-alpha in the treatment of moderate-to-severe COVID-19: a randomised clinical trial

Author:

Li Chuan1,Luo Fengming2,Liu Chengwu1,Xiong Nian34,Xu Zhihua5,Zhang Wei67,Yang Ming8,Wang Ye2,Liu Dan2,Yu Chao79,Zeng Jia710,Zhang Li11,Li Duo12,Liu Yanbin13,Feng Mei2,Liu Ruoyang14,Mei Jiandong1,Deng Senyi1,Zeng Zhen1,He Yuanhong15,Liu Haiyan16,Shi Zhengyu16,Duan Meng17,Kang Deying18,Liao Jiayu1920,Li Weimin2,Liu Lunxu1

Affiliation:

1. Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, China

2. Department of Pulmonary and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, China

3. Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

4. Wuhan Red Cross Hospital, Wuhan, China

5. Department of Critical Care Medicine, Mianyang Central Hospital, Mianyang, China

6. Department of Respiratory and Critical Care Medicine, First Affiliated Hospital, The Second Military Medical University, Shanghai, China

7. Department of Infectious Diseases, Guanggu District, the Maternal and Child Health Hospital of Hubei Province, Wuhan, China

8. Department of Respiratory Medicine, The Public Health Clinical Center of Chengdu, Chengdu, China

9. Department of Respiratory and Critical Care Medicine, Naval Hospital of Eastern Theater of PLA, Zhoushan, China

10. Department of Aviation Disease, Naval medical center of PLA, the Second Military Medical University, Shanghai, China

11. Department of Respiratory Disease, Wuhan Red Cross Hospital, Wuhan, China

12. Department of Respiratory Disease, The Affiliated Hospital of Southwest Medical University, Luzhou, China

13. Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China

14. Department of Respiratory Disease, Sichuan Second Hospital of T. C. M, Chengdu, China

15. Department of Infectious Disease, The Public Health Clinical Center of Chengdu, Chengdu, China

16. Department of Tuberculosis, The Public Health Clinical Center of Chengdu, Chengdu, China

17. Department of Liver Disease, The Public Health Clinical Center of Chengdu, Chengdu, China

18. Department of Evidence based Medicine and Clinical Epidemiology, West China Hospital, Sichuan University, Chengdu, China

19. Department of Bioengineering, Bourns College of Engineering, University of California, Riverside, CA, USA

20. The West China-California Research Center for Predictive Intervention Medicine, West China hospital, Sichuan University, Chengdu, China

Funder

New Coronavirus (2019-nCoV) Emergency Project of Sichuan University

Novel Coronavirus Pneumonia Epidemic Research Project in West China Hospital, Sichuan University

Publisher

Informa UK Limited

Subject

General Medicine

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3